Inventor

VALMORI DANILA

CH15 patents

⚠️ This page may combine multiple inventors who share the name “VALMORI DANILA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LUDWIG INST CANCER RES

11 patents

US6605711B1Aug 12, 2003

NY-ESO-1 peptide derivatives, and uses thereof

LUDWIG INST CANCER RES39 citations91

US6326200B1Dec 4, 2001

Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof

LUDWIG INST CANCER RES24 citations91

US6025470AFeb 15, 2000

Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

LUDWIG INST CANCER RES26 citations91

US6417165B1Jul 9, 2002

NY-ESO-1-peptide derivatives, and uses thereof

LUDWIG INST CANCER RES37 citations89

US6384190B1May 7, 2002

Isolated decapeptides which bind to HLA molecules

LUDWIG INST CANCER RES5 citations72

US6368857B1Apr 9, 2002

Method for provoking proliferation of cytolytic T cells via the use of decapeptides which complex with HLA-A2 molecules

LUDWIG INST CANCER RES8 citations72

US6277956B1Aug 21, 2001

Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

LUDWIG INST CANCER RES6 citations72

US7713714B2May 11, 2010

Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

LUDWIG INST CANCER RES0 citations51

US7344879B2Mar 18, 2008

Isolated nucleic acid molecules which encode peptides that bind to HLA molecules, and uses thereof

LUDWIG INST CANCER RES0 citations51

US7858743B2Dec 28, 2010

SSX-4 peptides presented by HLA class II molecules

LUDWIG INST CANCER RES0 citations49

US7429639B2Sep 30, 2008

SSX-2 peptides presented by HLA class II molecules

LUDWIG INST CANCER RES1 citations49

LUDWIG INST FOR CANCER RES LTD

3 patents

US8008464B2Aug 30, 2011

VALMORI DANILA

1 patent

US9200047B2Dec 1, 2015

SSX-2 peptides presented by HLA class II molecules

VALMORI DANILA0 citations43

VALMORI DANILA

LUDWIG INST CANCER RES

NY-ESO-1 peptide derivatives, and uses thereof

Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof

Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

NY-ESO-1-peptide derivatives, and uses thereof

Isolated decapeptides which bind to HLA molecules

Method for provoking proliferation of cytolytic T cells via the use of decapeptides which complex with HLA-A2 molecules

Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof

Isolated nucleic acid molecules which encode peptides that bind to HLA molecules, and uses thereof

SSX-4 peptides presented by HLA class II molecules

SSX-2 peptides presented by HLA class II molecules

LUDWIG INST FOR CANCER RES LTD

SSX-4 peptides presented by HLA class II molecules

SSX-2 peptides presented by HLA class II molecules

Ssx-2 peptides presented by hla class II molecules

VALMORI DANILA

SSX-2 peptides presented by HLA class II molecules